BioSpace News Archive

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced four projects selected to receive funding for clinical evaluation of axitinib.

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that the first patients have been enrolled in ASPEN-COVID-19, the Phase 2b clinical trial evaluating rNAPc2 (AB201) as a potential treatment for patients hospitalized with COVID-19.

Curebase, a company committed to democratizing access to clinical studies, today announced that Luminostics utilized the company’s virtual site solution to power clinical studies for its Clip COVID Rapid Antigen Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on December 7, 2020.

Explora BioLabs, a national provider of best-in-class vivarium research space and management services based here, will launch three new facilities in the San Francisco, Calif., region between Q1-Q3 2021.

Zomedica Corp. announced that while a majority of shareholders voted at its Special Virtual-Only Meeting of Shareholders held on December 15, 2020 in favor of the Company’s proposed domestication to Delaware, shareholders failed to approve the proposal by the necessary 2/3 vote and therefore the domestication will not be implemented.

Medela LLC, a global leader in medical vacuum technology, today announced that its Thopaz+ Digital Chest Drainage and Monitoring System* has undergone multiple quantitative tests that demonstrate its filtration system effectively blocks passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.